Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DART 01/05: Long-term vs Short-term Androgen Deprivation with Radiotherapy
NCT02175212Phase 3Completed
- Sponsor
- Fundación de Investigación Biomédica del Hospital Universitario de La Princesa
- Start
- Nov 2005
- Primary completion
- Jun 2014
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of goserelin in prostate adenocarcinoma, sponsored by Fundación de Investigación Biomédica del Hospital Universitario de La Princesa. Started Nov 2005; status: completed.
02
Drugs
goserelin
03
Conditions
prostate adenocarcinoma
Beyond the preview
Go deeper on NCT02175212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02175212.